Wrapmanager Inc Aerie Pharmaceuticals Inc Transaction History

Wrapmanager Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$4.95 - $9.16 $13,582 - $25,135	-2,744 Reduced 6.42%	39,988 $300,000
Q1 2022 May 10, 2022	BUY	$5.64 - $9.8 $54,386 - $94,501	9,643 Added 29.14%	42,732 $389,000
Q4 2021 Feb 07, 2022	SELL	$7.02 - $13.33 $28,058 - $53,280	-3,997 Reduced 10.78%	33,089 $232,000
Q3 2021 Nov 10, 2021	BUY	$11.32 - $16.63 $87,752 - $128,915	7,752 Added 26.43%	37,086 $423,000
Q2 2021 Aug 04, 2021	SELL	$15.16 - $18.97 $12,446 - $15,574	-821 Reduced 2.72%	29,334 $470,000

Q1 2021 May 10, 2021	SELL	$13.12 - $20.9 $160,103 - $255,042	-12,203 Reduced 28.81%	30,155 $539,000
Q4 2020 Feb 08, 2021	BUY	$9.12 - $14.49 $36,653 - $58,235	4,019 Added 10.48%	42,358 $572,000
Q3 2020 Nov 12, 2020	BUY	$10.46 - $14.46 $135,749 - $187,661	12,978 Added 51.17%	38,339 $451,000
Q2 2020 Aug 11, 2020	BUY	$12.0 - $16.13 $173,760 - $233,562	14,480 Added 133.08%	25,361 $374,000
Q1 2020 May 08, 2020	BUY	$11.84 - $25.52 $128,831 - $277,683	10,881 New	10,881 $147,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

Stay updated on Wrapmanager Inc with notifications on news.